Drug Type Diagnostic radiopharmaceuticals |
Synonyms [18F]UCB 2897 |
Target |
Action modulators |
Mechanism α-synuclein modulators(Synuclein alpha modulators) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple System Atrophy | Phase 1 | United States | 31 Jan 2022 | |
| Parkinson Disease | Phase 1 | United States | 31 Jan 2022 |





